JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 57(2023) N 4 p. 684-691; DOI 10.1134/S002689332304009X Full Text

F.Z. Jiang1, Q.J. Xia2, L. Wu3, Y.M. Zhang1*

Overexpression of MKRN2 Inhibits the Growth of Ovarian Cancer Cells

1Department of Obstetrics and Gynecology, Dushu Lake Hospital affiliated to Soochow University, Soochow University, Suzhou, China
2Obstetrics and Gynecology Department, Nantong Haimen District People's Hospital, Nantong, China
3Suzhou Industrial Park Centers for Disease Control and Prevention, Suzhou, China

*zhangyueming@suda.edu.cn
Received - 2022-10-21; Revised - 2022-12-05; Accepted - 2022-12-17

Ovarian cancer has a high mortality with low five-year survival rates. The role of the E3 ligase Makorin ring finger protein 2 (MKRN2) in ovarian cancer is unknown. This study investigated the impact of MKRN2 on the growth of ovarian cancer. MKRN2 expression in ovarian cancer tissue was analyzed by immunohistochemistry. Overexpression of MKRN2 was induced in two ovarian cancer cell lines (SKOV3 and CAOV3) by lentivirus transfection, and expression levels were verified by western blotting. Proliferation and growth were determined by CCK-8 and colony formation assays, while migration was examined using transwell assays and apoptosis by flow cytometry. Xenograft tumors of transfected SKOV3 cells were established in mice, and immunohistochemistry and TUNEL assays measured MKRN2 levels and apoptosis in tumor cells. Reduced levels of MKRN2 in cancerous tissue relative to non-cancerous ovarian tissues. Lentiviral-based MKRN2 overexpression in SKOV3 and CAOV3 cells reduced tumor-associated behavior while inducing apoptosis in vitro. In xenograft tumors, MKRN2 overexpression inhibited ovarian cancer growth and increased apoptosis in vivo. These findings imply the MKRN2 involvement in ovarian carcinogenesis and suggest its potential for treating the disease.

cell proliferation, cell migration, cell invasion, MKRN2, ovarian cancer



JMB-FOOTER RAS-JOURNALS